Non-invasive Brain Stimulation to Prepare the Patient for Bariatric Surgery (REBAS)

ConditionObesity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMasaryk University

About this trial

Obesity is a chronic metabolic condition characterized by excessive accumulation of body fat, which triggers physiological mechanisms that increase the risk of a wide range of health problems. The most effective treatment for severe obesity is metabolic-bariatric surgery, which can lead to a 15-20% weight reduction, significantly lowering the risks of illness and death. However, the success of this surgery can be threatened by poor eating habits after the procedure. The main goal of this study is to enhance the long-term effectiveness of bariatric surgery by combining it with non-invasive brain stimulation (tDCS) targeting inhibitory centers before the operation. Additionally, the investigators aim to comprehensively monitor patients before and after surgery, focusing on investigating changes in brain function associated with the achieved weight loss.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subjects with severe or morbid obesity (determined by BMI > 35 or 40 kg/m2, respectively) eligible for BS treatment in compliance with the current guidelines

Subjects who meet reduced control over eating behavior (disinhibition) criteria in the Eating Habits Questionnaire

Disqualifiers

Subjects unable to provide informed consent and those unable to understand and cooperate with study-related procedures (based on the physician's discretion)

Subjects with a personal history of ischemic heart disease, myocardial infarction, stroke, heart failure, and atrial fibrillation

Subjects who have already undergone BS treatment in the past

Pregnant subjects or subjects that plan on becoming pregnant during the study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • home-based tDCS stimulation

    Device

    stimulation parameters: 20 sessions of tDCS over lDLPFC (anode over F3, based on the 10:20 system, and cathode over the right supraorbital area), 2 mA intensity, 20 min duration (30 s fade in/fade out)

  • home-based tDCS stimulation - sham

    Device

    20 sessions of tDCS over lDLPFC (anode over F3, based on the 10:20 system, and cathode over the right supraorbital area), the electric current will flow for only 15 s, with similar fade in/fade out, at the beginning and at the end of 20 min, to mimic the subjective sensations that occur during active tDCS.

  • Bariatric surgery

    Procedure/Surgery

    The operation itself is not a study-related procedure and thus the indicated patients would undergo the surgery regardless of their participation in this study. The operating surgeons will perform either Roux-en-Y or gastric sleeve resection.

Treatment groups

65 Participants
are divided into 2 treatment groups
Group A: active tDCS stimulationExperimental treatment 2 interventions
Group B: sham tDCS stimulationSham comparator 2 interventions

Trial outcomes

Primary outcomes

1

Cognitive impulse control measured via food-modified Go/No-Go task

The cognitive task is used to assess response inhibition, particularly in the context of food-related stimuli. It is a variation of the standard Go/No-Go task, where participants must respond quickly to "Go" stimuli (low-calorie item) while withholding responses to "No-Go" stimuli (high-calorie item). Researchers analyze reaction times, accuracy, and commission errors (responses to No-Go stimuli) to evaluate impulse control.

Time frame
Baseline, 1 month and 6 months.

Secondary outcomes

1

Brain activation related to cognitive control assessed using a multichannel EEG system

The investigators will evaluate brain activity in response to food-modified Go/No-Go stimuli and during rest, using Time-Frequency Analysis, focusing on theta and beta power.

Time frame
Baseline, 1 month and 6 months.
2

Body bioimpedance analysis measured with the InBody 720 device

Patients, wearing light clothing and standing barefoot with their legs slightly apart, will hold the device's sensors. Within seconds, the device calculates parameters such as total body water, fat mass, muscle mass, and segmental composition.

Time frame
Baseline, 1 month and 6 months.
3

Food craving of patients assessed using Food Craving Questionnaire - Trait

The questionnaire has 21 items with a response scale 1-6, higher score means stronger cravings.

Time frame
Baseline, 1 month and 6 months.
4

Eating habits of patients assessed using the Three-Factor Eating Questionnaire

The Questionnaire has 51 items in total, 36 items ask for true/false judgment, and 15 items are scored on a 4-point Likert-type scale, each item scores either 0 or 1 point, the minimum score for factors Cognitive Restraint, Disinhibition, and Hunger is 0-0-0, the possible maximum score is 21-16-14.

Time frame
Baseline, 1 month and 6 months.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Masaryk University

Lead sponsor

St. Anne's University Hospital Brno, Czech Republic

Collaborator